戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 a pathogenetic feature shared by parasitized thalassemic and G6PD-deficient RBCs, triggering abnormal
2 in the spleen, bone marrow, and liver of the thalassemic animals.
3                             As a result, the thalassemic beta-globin pre-mRNAs are spliced almost exc
4                                     For beta-thalassemic CD34(+) cells, similar gene transfer efficie
5                                              Thalassemic cells were associated with expression of cel
6                                  In isolated thalassemic cells, short-term proteasome inhibition bloc
7         This is the first reported case of a thalassemic condition that is maintained in a species as
8             These mice mimic the human alpha-thalassemic conditions and can be used as preclinical mo
9 n this locus such as sickle cell disease and thalassemic diseases.
10 icant overexpression of beta-globin in alpha-thalassemic disorders.
11 ate from the blood cells of one of four beta-thalassemic donors and 3H-alpha-chains or 3H-alpha-globi
12 ng effect on somatic recombination events in thalassemic embryos.
13 s, with heme attached to them, accumulate in thalassemic erythroblasts causing oxidative stress and t
14                                      In beta-thalassemic erythrocyte precursors, free alpha-globin wa
15 rovide a framework for studying the enhanced thalassemic erythroid apoptosis.
16 vel of total endogenous alpha-globin mRNA in thalassemic erythroid cells resulted in improved red cel
17 ances translation of ATF4 mRNA in mouse beta-thalassemic erythroid precursors.
18 globin gene will be required to improve beta-thalassemic erythropoiesis?
19 larly effective in individuals carrying beta-thalassemic gene defects.
20 t proteolysis pathway in unfractionated beta-thalassemic hemolysates.
21                  Mice transplanted with beta-thalassemic HSCs transduced with a gamma-globin/MGMT vec
22                 Using BALB/c donors and beta-thalassemic HW-80 recipients, we found significantly imp
23 experiments performed on blood from HbE/beta thalassemics in the temperature range 39 degrees C to 41
24 s substitutes for deficient adult globins in thalassemic individuals.
25 ls of thalassemia, aberrant splicing of beta-thalassemic IVS2-705 pre-mRNA was permanently corrected
26  was increased in splenic erythroblasts from thalassemic mice and in erythroblasts and sera from subj
27                           Generation of beta-thalassemic mice chimeric for a minority proportion of g
28 r deferiprone (L1) intraperitoneally to beta-thalassemic mice for 4 wk and then studied RBC survival
29 Erfe and the consequences of its ablation in thalassemic mice from 3 to 12 weeks of age.
30      These cells were transplanted into beta-thalassemic mice given nonmyeloablative pretransplantati
31                      Serial analyses of beta-thalassemic mice indicate that while hemoglobin levels d
32                          The loss of ERFE in thalassemic mice led to full restoration of hepcidin mRN
33 e increase in expression of hepcidin in beta-thalassemic mice limits iron overload, decreases formati
34  in utero transplantation in nonanemic, beta-thalassemic mice to study chimerism, tolerance, and chan
35 eparate set of independent experiments, beta-thalassemic mice were bred with transgenic mice that exp
36                                    Moreover, thalassemic mice with established iron overload had sign
37                                 Injection of thalassemic mice with SCF plus nanoparticles containing
38 ontrast, prolonged in vivo treatment of beta-thalassemic mice with the proteasome inhibitor bortezomi
39 as been shown to be highly expressed in beta-thalassemic mice, restores hepcidin levels and corrects
40                                           In thalassemic mice, we observed that a greater than normal
41 s confirmed by up-regulation of TfR2 in beta-thalassemic mice, which, like hypotransferrinemic mice,
42 sg1 expression were performed in healthy and thalassemic mice.
43 d a Jak2 inhibitor, TG101209, to healthy and thalassemic mice.
44 xpression by 52%, yielding 9 g Hb/VC in beta-thalassemic mice.
45  production and correction of anemia in beta-thalassemic mice.
46  Transfection of HeLa cells expressing the 3 thalassemic mutants with modified U7 snRNA (U7.623), con
47 HbCS) is the most common nondeletional alpha-thalassemic mutation and is an important cause of HbH-li
48 rable populations of hemoglobin E (HbE)/beta thalassemics, one regularly transfused and one receiving
49 learance of rigid pathological cells such as thalassemic or sickle cells, and even to interactions of
50           In this study, CD34+ cells from 31 thalassemic patients mobilized with hydroxyurea+granuloc
51 rythropoietic cells from transgenic mice and thalassemic patients suggests the applicability of this
52   Mononuclear cells from peripheral blood of thalassemic patients were treated with morpholino oligon
53                                 Seventy-nine thalassemic patients without a history of chelation ther
54        Our data indicate that in a number of thalassemic patients, subpopulations of red cells circul
55  the improvement of hemolytic anemia in beta-thalassemic patients.
56  Hamp modulation provides improvement of the thalassemic phenotype of the Hbb(th3/+) mouse.
57 s can result in severe and frequently lethal thalassemic phenotypes.
58 errant 5' or 3' splice sites in the IVS2-705 thalassemic pre-mRNA.
59            This premature destruction of the thalassemic RBC could in part be due to a loss of phosph
60 he presence of PS-exposing subpopulations of thalassemic RBC that are most likely physiologically imp
61 n deposits contribute to the pathobiology of thalassemic RBC.
62   Analysis by fluorescent microscopy of beta-thalassemic RBCs indicates that PS on the outer leaflet
63  The results indicate that in the context of thalassemic splicing mutations and possibly in other alt
64 of animals that received transplants of beta-thalassemic stem cells transduced with a new vector cont
65                    Without iron-deficient or thalassemic subjects, the difference had narrowed to 6.1
66 lobin genes in mice results in corresponding thalassemic syndromes that are uniformly fatal in utero.
67  the molecular abnormalities that led to the thalassemic syndromes, it still is not known how accumul
68 zed membranes from HbCS and deletional alpha-thalassemic variants and found that in addition to oxidi
69 s more severe when compared with other alpha-thalassemic variants.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。